Navigation Links
High rate of complicated idiopathic gallstone disease in pediatric patients
Date:4/30/2008

The prevalence of gallstones in adults of industrialized countries is approximately 10% and is showing a tendency to rise. Data for pediatric patients is scarce.

A research article published on March 14, 2008, in the World Journal of Gastroenterology addresses this problem. The team lead by Dr. Denise Herzog from Sainte Justine Hospital, University of Montreal, Canada, has reviewed the rate of gallstone disease and its mode of presentation in pediatric patients requiring abdominal ultrasound at Sainte Justine Hospital between 2003 and 2005.

According to their results, idiopathic gallstone disease and complicated disease presentation were much more frequent than expected from previous studies, and it presented as complicated disease in 58% of patients, especially in adolescent girls.

The authors recommend that pediatricians become more aware of this disease, which until now was associated with adult patients only. In the light of the recent detection of the human Lith gene ABCG5/G8 and its association with the risk of cholesterol gallstone formation, the value of genetic evaluations of such families in order to prevent complicated disease presentation should be discussed. Further epidemiological data is required to decide whether genetic screening of families will help to prevent complicated disease presentation.


'/>"/>

Contact: Jing Zhu
wjg@wjgnet.com
0086-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
2. MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections
3. MIT: Stem-cell therapies for brain more complicated than thought
4. Depression in the Elderly is Complicated but Treatable, From the Harvard Mental Health Letter
5. Flip-chart book translates complicated medical procedures into easy-to-understand language
6. Admission-Day Crowding May Increase Hospital Stay for Children With Less Complicated Illnesses
7. Eltrombopag studied in Idiopathic Thrombocytopenic Purpura
8. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
9. Exclusion of common bile duct stones prior to gallstone operations
10. Early surgical treatment contributes to better outcomes in gallstone pancreatitis cases
11. U of I study: exercise to avoid gallstones!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Resoundant, Inc., the developer of Magnetic ... annual customer education symposium, a world-class learning conference that offers educational content designed ... 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations for ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of all holidays (IBT World Travel Trends Report). As travelers visit both urban ... range in temperatures, and prolonged sun exposure. In response, the outdoor industry has ...
(Date:3/28/2017)... ... ... Alert Sentry Group LLC., a leader in the Personal Emergency Response System industry, introduced ... Plus. These iSAFE products are the most affordable and most advanced medical alert systems ... direct GPS Location and two-way calling with the push of a button on a ...
(Date:3/28/2017)... ... , ... The Radiology Business Management Association (RBMA) is pleased to ... executive director. Mr. Still was selected through a careful months-long search by the RBMA ... known to our members, has been a part of building the RBMA since 1992,” ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , a provider ... and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and ... biometric face recognition to enable users to check in and out from anywhere ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... . This new business entity, Emosis Ltd, headquartered in ... and development of novel assays complementing the mother company existing technology ... support commercialization and sales development of Emosis kits. ... This strategic move starts building Emosis ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
Breaking Medicine Technology: